
Yang (Mao) Mao-Draayer MD
Associate Professor, Neurology, University of Michigan Medical School
Join to View Full Profile
28595 Orchard Lake RdSte 200Farmington Hills, MI 48334
Phone+1 248-553-0010
Fax+1 248-553-5957
Dr. Mao-Draayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Vermont Medical CenterResidency, Neurology, 2000 - 2003
- Texas Tech University Health Sciences Center at LubbockInternship, Transitional Year, 1999 - 2000
- Peking Union Medical CollegeClass of 1990
Certifications & Licensure
- MI State Medical License 2012 - 2028
- OK State Medical License 2024 - 2026
- VT State Medical License 2000 - 2012
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Mechanistic Studies of Teriflunomide in RRMS Start of enrollment: 2018 Apr 17
Publications & Presentations
PubMed
- Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon
Journal of Neuroimmunology. 2025-06-15 - Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein ...Sara Samadzadeh, Frederike Cosima Oertel, Hadi Salih, Ting-Yi Lin, Seyedamirhosein Motamedi
European Journal of Neurology. 2025-06-01 - Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, Gautam Sule, Carmelo Carmona-Rivera
JCI Insight. 2025-05-08
Press Mentions
- OMRF Receives $3.8 Million to Study Autoimmune DiseasesAugust 12th, 2024
- OMRF Welcomes New MS Neurologist-ScientistJune 6th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: